| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Dec'17 | Sep'17 | Jun'17 | Mar'17 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||
Research and development collaborations (note 9) | ||||||||||||
8,269 | 1,877 | 7,860 | 7,882 | 11,925 | 28,925 | 2,054 | 22,000 | 40 | 50,071 | 119 | 1,342 | 230 |
Operating expenses: | ||||||||||||
Research and development | ||||||||||||
36,526 | - | 29,251 | 23,785 | 17,475 | - | 14,195 | 15,368 | 13,085 | - | 11,525 | 8,289 | 9,058 |
Government grants and credits | ||||||||||||
- | - | - | - | - | - | - | - | - | - | 0 | 0 | 218 |
Net research and development | ||||||||||||
- | - | - | - | - | - | - | - | - | - | 11,525 | 8,289 | 8,840 |
General and administrative | ||||||||||||
7,623 | 30,240 | 12,173 | 12,761 | 9,003 | 6,296 | 7,447 | 8,648 | 7,066 | 4,715 | 5,291 | 2,285 | 6,259 |
Impairment on acquired IPR&D (note 6) | ||||||||||||
- | - | - | 768 | - | - | - | - | - | 0 | 0 | 0 | 1,536 |
Total operating expenses | ||||||||||||
44,149 | 75,629 | 41,424 | 37,314 | 26,478 | 20,574 | 21,642 | 24,016 | 20,151 | 17,205 | 16,816 | 10,574 | 16,635 |
Loss from operations | ||||||||||||
-35,880 | -73,752 | -33,564 | -29,432 | -14,553 | 8,351 | -19,588 | -2,016 | -20,111 | 32,866 | -16,697 | -9,232 | -16,405 |
Other income (expense): | ||||||||||||
Interest income | ||||||||||||
1,869 | - | - | - | 1,262 | - | - | - | - | - | - | - | - |
Interest and other expense | ||||||||||||
- | - | 33 | 65 | - | - | 166 | 5 | 8 | - | 2 | 179 | 227 |
Change in fair value of warrant liabilities | ||||||||||||
- | - | - | - | - | - | 0 | 2,223 | 1,342 | - | -187 | -1,578 | -555 |
Accretion on long-term debt | ||||||||||||
- | - | - | - | - | - | - | - | - | - | 0 | 160 | 88 |
Interest and other income | ||||||||||||
- | - | 2,097 | 1,233 | - | 977 | 1,131 | 272 | 258 | 155 | 210 | 328 | 50 |
Other income (expenses), net (note 10) | ||||||||||||
3,250 | - | - | - | -157 | - | - | - | - | - | - | - | - |
Foreign exchange (loss) gain | ||||||||||||
- | - | 117 | -178 | - | - | -79 | -60 | -66 | - | 107 | -64 | 189 |
Loss on debt extinguishment | ||||||||||||
- | - | - | - | - | - | - | - | - | - | - | -3,114 | - |
Total other income (expense), net | ||||||||||||
5,119 | 1,006 | 2,181 | 990 | 1,105 | 1,267 | 886 | -2,016 | -1,158 | 136 | 502 | -1,611 | 479 |
Loss before income taxes | ||||||||||||
-30,761 | -72,746 | -31,383 | -28,442 | -13,448 | 9,618 | -18,702 | -4,032 | -21,269 | 33,002 | -16,195 | -10,843 | -15,926 |
Current income tax recovery (expense) | ||||||||||||
- | - | -710 | 688 | - | - | 168 | 1,919 | -87 | - | 35 | 162 | - |
Deferred income tax recovery | ||||||||||||
- | - | -198 | -53 | - | - | -119 | -77 | 22 | - | 15 | -37 | - |
Income tax expense | ||||||||||||
375 | - | - | - | 193 | - | - | - | - | - | - | - | - |
Net loss and comprehensive loss | ||||||||||||
-31,136 | -72,244 | -30,475 | -29,077 | -13,641 | 9,273 | -18,751 | -5,874 | -21,204 | 32,733 | -16,245 | -10,968 | -15,926 |
Net loss per common share (note 4): | ||||||||||||
Basic and diluted (in dollars per share) | ||||||||||||
-0.64 | - | - | - | -0.43 | - | - | - | - | - | - | - | - |
Basic | ||||||||||||
- | - | -0.70 | -0.89 | - | 0.38 | -0.59 | -0.22 | -0.83 | 1.89 | -0.64 | -0.55 | -1.21 |
Diluted | ||||||||||||
- | - | -0.70 | -0.89 | - | 0.38 | -0.59 | -0.22 | -0.83 | 1.89 | -0.65 | -0.63 | -1.25 |
Weighted-average common shares outstanding (note 4): | ||||||||||||
Basic and diluted (in shares) | ||||||||||||
48,686 | - | - | - | 32,020 | - | - | - | - | - | - | - | - |
Basic | ||||||||||||
- | - | 43,445 | 32,837 | - | 32,071 | 31,959 | 26,869 | 25,459 | 25,558 | 25,339 | 20,915 | 13,183 |
Diluted | ||||||||||||
- | - | 43,445 | 32,837 | - | 32,071 | 31,959 | 26,869 | 25,459 | 25,567 | 25,349 | 21,038 | 13,329 |